Pandemic-Related Shifts in New Patients Admitted to Children's Hospitals

Nicholas A Clark1,2, Jonathan Rodean3, Marcos Mestre4

  • 1Division of Hospital Medicine, Children's Mercy Kansas City, Kansas City, Missouri nclark1@cmh.edu.

Hospital Pediatrics
|June 2, 2021
PubMed

Insights

During the coronavirus disease 2019 pandemic, children's hospitals saw more new patients, linked to local severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission rates. Pediatric care consolidation may have increased, but its impact on patient outcomes remains unclear.

Area of Science:

  • Pediatric healthcare research
  • Epidemiology
  • Public health policy

Background:

  • Professional organizations recommended transferring pediatric patients to children's hospitals during the COVID-19 pandemic.
  • This shift aimed to consolidate care, potentially increasing the number of new patients at specialized facilities.

Purpose of the Study:

  • To describe changes in new patient encounters at children's hospitals during the early COVID-19 pandemic.
  • To investigate the association between local SARS-CoV-2 incidence and new patient admissions.

Main Methods:

  • Retrospective cohort study of pediatric patients (6 months–18 years) admitted to children's hospitals.
  • Comparison between a control period (March 15–June 30, 2019) and the pandemic period (2020).
  • Analysis adjusted for diagnosis and stratified by local SARS-CoV-2 transmission levels.

Main Results:

  • New patient encounters increased during the pandemic period (46.4% vs. 44.7%).
  • After adjusting for diagnosis, the proportion of new patients did not significantly differ between periods (aOR 1.00).
  • Higher local SARS-CoV-2 transmission was associated with a greater likelihood of new patient admissions (aORs 1.08–1.09).

Conclusions:

  • The increase in new pediatric patients during the early pandemic was partly explained by diagnostic shifts and local SARS-CoV-2 transmission.
  • Evidence suggests potential pediatric care consolidation occurred.
  • The impact of this consolidation on hospitalized children's outcomes requires further investigation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
57
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
454